Positron emission tomography with computed tomography imaging (PET/CT) for the radiotherapy planning definition of the biological target volume: PART 2.


Journal

Critical reviews in oncology/hematology
ISSN: 1879-0461
Titre abrégé: Crit Rev Oncol Hematol
Pays: Netherlands
ID NLM: 8916049

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 05 02 2019
revised: 14 03 2019
accepted: 14 03 2019
pubmed: 4 4 2019
medline: 10 9 2019
entrez: 4 4 2019
Statut: ppublish

Résumé

Positron Emission Tomography with Computed Tomography (PET/CT) has been proven to be useful in the definition of Radiotherapy (RT) target volume. In this regard, the present expert review summarizes existing data for pancreas, prostate, gynecological and rectum/anal cancer. A comprehensive search of published original article was made, based on SCOPUS and PubMed database, selecting the paper that evaluated the role of PET/CT in the definition of RT volume. FDG-PET has an important and promising role for pancreatic cancer. Choline PET/CT could be useful for identifying high-risk volumes for prostate cancer; while PSMA PET/CT is still under evaluation. FDG PET/CT in gynecological cancers has been shown to impact external-beam RT planning. The role of FDG-PET for Gross Tumor volume identification is crucial, representing a useful and powerful tool for anal and rectal cancer. Taken together, molecular and functional imaging approaches offer a major step to individualize radiotherapeutic approach.

Identifiants

pubmed: 30940428
pii: S1040-8428(19)30060-5
doi: 10.1016/j.critrevonc.2019.03.008
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

117-124

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Alba Fiorentino (A)

Radiotherapy Oncology Department, General Regional Hospital "F. Miulli", Acquaviva delle Fonti-Bari, Italy. Electronic address: a.fiorentino@miulli.it.

Riccardo Laudicella (R)

Department of Biomedical and Dental Sciences and of Morphofunctional Imaging, University of Messina, Italy.

Elisa Ciurlia (E)

Radiotherapy Oncology Department, Vito Fazzi Hospital, Lecce, Italy.

Salvatore Annunziata (S)

Fondazione Policlinico A. Gemelli IRCCS-Università Cattolica Sacro Cuore, Roma, Italy.

Valentina Lancellotta (V)

Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC di Radioterapia, Dipartimento di Scienze Radiologiche, Radioterapiche ed Ematologiche, Roma, Italy.

Paola Mapelli (P)

Department of Nuclear Medicine, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Carmelo Tuscano (C)

Radiotherapy Oncology Department, Azienda Ospedaliera Bianchi-Melacrino-Morelli, Reggio Calabria, Italy.

Federico Caobelli (F)

Clinic of Radiology and Nuclear Medicine, University Hospital Basel, University of Basel, Basel, Switzerland.

Laura Evangelista (L)

Nuclear Medicine Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.

Lorenza Marino (L)

Radiotherapy Oncology Department, REM, Viagrande, Catania, Italy.

Natale Quartuccio (N)

Nuclear Medicine Unit, ARNAS Civico Palermo, Palermo, Italy.

Michele Fiore (M)

Radiation Oncology, Campus Bio-Medico University, Rome, Italy.

Paolo Borghetti (P)

Radiation Oncology Department University and Spedali Civili, Brescia, Italy.

Agostino Chiaravalloti (A)

IRCCS Istituto Neurologico Mediterraneo (INM) Neuromed, Pozzilli, Italy; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Italy.

Maria Ricci (M)

Department of Radiological, Oncological and Pathological Sciences, Sapienza University of Rome, Rome, Italy.

Isacco Desideri (I)

Department of Biomedical, Experimental and Clinical Sciences "Mario Serio", Section of Radiation Oncology, University of Florence, Italy.

Pierpaolo Alongi (P)

Department of Radiological Sciences, Nuclear Medicine Service, Fondazione Istituto G. Giglio, Cefalu, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH